The Histone Demethylase KDM3A Regulates the Transcriptional Program of the Androgen Receptor in Prostate Cancer Cells

Overview

Journal Oncotarget

Specialty Oncology

Date 2017 Apr 19

PMID 28416760

Citations 48

Authors

Stephen Wilson

Lingling Fan

Natasha Sahgal

Jianfei Qi

Fabian V Filipp

Affiliations

Soon will be listed here.

Abstract

The lysine demethylase 3A (KDM3A, JMJD1A or JHDM2A) controls transcriptional networks in a variety of biological processes such as spermatogenesis, metabolism, stem cell activity, and tumor progression. We matched transcriptomic and ChIP-Seq profiles to decipher a genome-wide regulatory network of epigenetic control by KDM3A in prostate cancer cells. ChIP-Seq experiments monitoring histone 3 lysine 9 (H3K9) methylation marks show global histone demethylation effects of KDM3A. Combined assessment of histone demethylation events and gene expression changes presented major transcriptional activation suggesting that distinct oncogenic regulators may synergize with the epigenetic patterns by KDM3A. Pathway enrichment analysis of cells with KDM3A knockdown prioritized androgen signaling indicating that KDM3A plays a key role in regulating androgen receptor activity. Matched ChIP-Seq and knockdown experiments of KDM3A in combination with ChIP-Seq of the androgen receptor resulted in a gain of H3K9 methylation marks around androgen receptor binding sites of selected transcriptional targets in androgen signaling including positive regulation of KRT19, NKX3-1, KLK3, NDRG1, MAF, CREB3L4, MYC, INPP4B, PTK2B, MAPK1, MAP2K1, IGF1, E2F1, HSP90AA1, HIF1A, and ACSL3. The cancer systems biology analysis of KDM3A-dependent genes identifies an epigenetic and transcriptional network in androgen response, hypoxia, glycolysis, and lipid metabolism. Genome-wide ChIP-Seq data highlights specific gene targets and the ability of epigenetic master regulators to control oncogenic pathways and cancer progression.

Citing Articles

Transcriptomic Profile Analysis of Brain Tissue in the Absence of Functional TRPM8 Calcium Channel.

Saldes E, Erdmier A, Velpula J, Koeltzow T, Zhu M, Asuthkar S Biomedicines. 2025; 13(1).

PMID: 39857659 PMC: 11760472. DOI: 10.3390/biomedicines13010075.

Epigenetic roles of KDM3B and KDM3C in tumorigenesis and their therapeutic implications.

Yoo J, Kim G, Jeon Y, Lee S, Kwon S Cell Death Dis. 2024; 15(6):451.

PMID: 38926399 PMC: 11208531. DOI: 10.1038/s41419-024-06850-z.

A Meta-Analysis Approach to Gene Regulatory Network Inference Identifies Key Regulators of Cardiovascular Diseases.

Pepe G, Appierdo R, Ausiello G, Helmer-Citterich M, Gherardini P Int J Mol Sci. 2024; 25(8).

PMID: 38673810 PMC: 11049946. DOI: 10.3390/ijms25084224.

Knockout of KDM3A in MDA-MB-231 breast cancer cells inhibits tumor malignancy and promotes apoptosis.

Han Y, Maimaiti N, Sun Y, Yao J J Mol Histol. 2024; 55(1):139-148.

PMID: 38165573 PMC: 10830655. DOI: 10.1007/s10735-023-10178-x.

Histone Demethylase KDM3 (JMJD1) in Transcriptional Regulation and Cancer Progression.

Fan L, Sudeep K, Qi J Adv Exp Med Biol. 2023; 1433:69-86.

PMID: 37751136 PMC: 11052651. DOI: 10.1007/978-3-031-38176-8_4.

References

Kleine-Kohlbrecher D, Christensen J, Vandamme J, Abarrategui I, Bak M, Tommerup N . A functional link between the histone demethylase PHF8 and the transcription factor ZNF711 in X-linked mental retardation. Mol Cell. 2010; 38(2):165-78. PMC: 2989439. DOI: 10.1016/j.molcel.2010.03.002. View

Oktem G, Bilir A, Uslu R, Inan S, Demiray S, Atmaca H . Expression profiling of stem cell signaling alters with spheroid formation in CD133/CD44 prostate cancer stem cells. Oncol Lett. 2014; 7(6):2103-2109. PMC: 4049671. DOI: 10.3892/ol.2014.1992. View

Subramanian A, Tamayo P, Mootha V, Mukherjee S, Ebert B, Gillette M . Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005; 102(43):15545-50. PMC: 1239896. DOI: 10.1073/pnas.0506580102. View

Echeverria P, Picard D . Molecular chaperones, essential partners of steroid hormone receptors for activity and mobility. Biochim Biophys Acta. 2009; 1803(6):641-9. DOI: 10.1016/j.bbamcr.2009.11.012. View

Shaw G, Whitaker H, Corcoran M, Dunning M, Luxton H, Kay J . The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer. Eur Urol. 2015; 70(2):214-8. PMC: 4926724. DOI: 10.1016/j.eururo.2015.10.042. View

Chen S, Chen K, Zhang Q, Cheng H, Zhou R . Regulation of the transcriptional activation of the androgen receptor by the UXT-binding protein VHL. Biochem J. 2013; 456(1):55-66. DOI: 10.1042/BJ20121711. View

Kasioulis I, Syred H, Tate P, Finch A, Shaw J, Seawright A . Kdm3a lysine demethylase is an Hsp90 client required for cytoskeletal rearrangements during spermatogenesis. Mol Biol Cell. 2014; 25(8):1216-33. PMC: 3982988. DOI: 10.1091/mbc.E13-08-0471. View

Scharte M, Han X, Bertges D, Fink M, Delude R . Cytokines induce HIF-1 DNA binding and the expression of HIF-1-dependent genes in cultured rat enterocytes. Am J Physiol Gastrointest Liver Physiol. 2002; 284(3):G373-84. DOI: 10.1152/ajpgi.00076.2002. View

Qiao S, Tuohimaa P . The role of long-chain fatty-acid-CoA ligase 3 in vitamin D3 and androgen control of prostate cancer LNCaP cell growth. Biochem Biophys Res Commun. 2004; 319(2):358-68. DOI: 10.1016/j.bbrc.2004.05.014. View

10.

Kooistra S, Helin K . Molecular mechanisms and potential functions of histone demethylases. Nat Rev Mol Cell Biol. 2012; 13(5):297-311. DOI: 10.1038/nrm3327. View

11.

Pretlow T, WOLMAN S, Micale M, Pelley R, Kursh E, Resnick M . Xenografts of primary human prostatic carcinoma. J Natl Cancer Inst. 1993; 85(5):394-8. DOI: 10.1093/jnci/85.5.394. View

12.

Jain G, Voogdt C, Tobias A, Spindler K, Moller P, Cronauer M . IκB kinases modulate the activity of the androgen receptor in prostate carcinoma cell lines. Neoplasia. 2012; 14(3):178-89. PMC: 3323896. DOI: 10.1593/neo.111444. View

13.

Wade M, Jones D, Wilson L, Stockley J, Coffey K, Robson C . The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer. Nucleic Acids Res. 2014; 43(1):196-207. PMC: 4288188. DOI: 10.1093/nar/gku1298. View

14.

Bjorkman M, Ostling P, Harma V, Virtanen J, Mpindi J, Rantala J . Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion. Oncogene. 2011; 31(29):3444-56. DOI: 10.1038/onc.2011.512. View

15.

Lunardi P, Beauval J, Roumiguie M, Soulie M, Cuvillier O, Malavaud B . [Mechanisms of castration resistance: Intratumoral hypoxia stimulates the androgen receptor expression]. Prog Urol. 2016; 26(3):159-67. DOI: 10.1016/j.purol.2016.01.004. View

16.

Sowalsky A, Xia Z, Wang L, Zhao H, Chen S, Bubley G . Whole transcriptome sequencing reveals extensive unspliced mRNA in metastatic castration-resistant prostate cancer. Mol Cancer Res. 2014; 13(1):98-106. PMC: 4312515. DOI: 10.1158/1541-7786.MCR-14-0273. View

17.

Georget V, Terouanne B, Nicolas J, Sultan C . Mechanism of antiandrogen action: key role of hsp90 in conformational change and transcriptional activity of the androgen receptor. Biochemistry. 2002; 41(39):11824-31. DOI: 10.1021/bi0259150. View

18.

Bain D, Heneghan A, Connaghan-Jones K, Miura M . Nuclear receptor structure: implications for function. Annu Rev Physiol. 2006; 69:201-20. DOI: 10.1146/annurev.physiol.69.031905.160308. View

19.

Yamada D, Kobayashi S, Yamamoto H, Tomimaru Y, Noda T, Uemura M . Role of the hypoxia-related gene, JMJD1A, in hepatocellular carcinoma: clinical impact on recurrence after hepatic resection. Ann Surg Oncol. 2011; 19 Suppl 3:S355-64. DOI: 10.1245/s10434-011-1797-x. View

20.

Huang W, Li X, Liu J, Lin J, Chung L . Activation of androgen receptor, lipogenesis, and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells. Mol Cancer Res. 2011; 10(1):133-42. PMC: 3262123. DOI: 10.1158/1541-7786.MCR-11-0206. View